Restenosis risk factors after coronary stenting in metabolic syndrome patients
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus. Recently, MS has also been regarded as a pathology enhancing coronary restenosis risk. Certain...
Saved in:
| Main Authors: | N. M. Danilov, T. T. Gorgadze, A. P. Savchenko, I. E. Chazova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1207 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01) -
Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01) -
Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01) -
Research advances in the etiology of in-stent restenosis of coronary arteries
by: Hangrui Bai, et al.
Published: (2025-07-01) -
Management of in-stent restenosis after iliofemoral venous stenting
by: XU Huimin, GAO Hongxia
Published: (2024-11-01)